Mu Wang
Professor
Department of Patient Care
UNION OF INTERNATIONAL ASSOCIATIONS (UIA)
Bahamas
Biography
Dr. Wang is the Director of Proteomics and an Associate Professor of Biochemistry and Molecular Biology at the Indiana University School of Medicine. He earned his PhD in BioOrganic Chemistry from Washington University in St Louis Missouri and was an NIH/NRSA postdoctoral fellow for studying mechanisms of DNA repair in mammalian system. He joined the Indiana University School of Medicine in 2001 as the Scientific Director of Proteomics and established a Proteomics Core Facility. His expertise includes 2DE and LC/MSbased proteomics DNA repair surface plasmon resonance and cancer drug resistance He has supervised many graduate students postdoctoral fellows and research associates. He is also a CoPrincipal Investigator on the National Cancer Institute’s Clinical Proteomics Technologies for Cancer Program and has worked with many clinical investigators worldwide. He received a number of awards including a Young Investigator’s Award in 2004 HUPO meeting. He has published more than 60 peer reviewed articles in DNA repair biochemistry and proteomics related journals and served as a reviewer for many journals as well as NIH and Department of Defense grant applications. Dr. Wang is the Director of Proteomics and an Associate Professor of Biochemistry and Molecular Biology at the Indiana University School of Medicine. He earned his PhD in BioOrganic Chemistry from Washington University in St Louis Missouri and was an NIH/NRSA postdoctoral fellow for studying mechanisms of DNA repair in mammalian system. He joined the Indiana University School of Medicine in 2001 as the Scientific Director of Proteomics and established a Proteomics Core Facility. His expertise includes 2DE and LC/MSbased proteomics DNA repair surface plasmon resonance and cancer drug resistance He has supervised many graduate students postdoctoral fellows and research associates. He is also a CoPrincipal Investigator on the National Cancer Institute’s Clinical Proteomics Technologies for Cancer Program and has worked with many clinical investigators worldwide. He received a number of awards including a Young Investigator’s Award in 2004 HUPO meeting. He has published more than 60 peer reviewed articles in DNA repair biochemistry and proteomics related journals and served as a reviewer for many journals as well as NIH and Department of Defense grant applications.
Research Interest
Molecular Mechanisms of DNA Damage and Repair,Cancer Biomarker Development including Early Detection for Breast Cancer and Ovarian Cancer, Drug Targets for Platinum Resistance, and Prognostic Signatures for Ataxia-Telangiectasia, New Methodology Development for Targeted Protein Assays and Small-Molecule/siRNA Drug Delivery